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1. Introduction 
Cancer is a very delicate subject, with various factors 
triggering the unregulated growth of cells. Broadly, cancers can be 
triggered by genetic, dietary and environmental factors. Statistically, 
only 5-10% of cancers are due to the genetic predisposition of the 
individual, which means 90-95% are due to environmental/dietary 
factors [2].Off late, people readily opt for heavily processed foods and 
do not pay much attention to the portion size, or the nutritional 
quality of their meals. Repeated intake of such heavily processed 
products may affect the metabolism and the growth of somatic cells. 
Many studies show that cancer can be easily prevented through 
lifestyle and diet changes [3–5]. 
 
Figure 1: Major factors contributing to Cancer [2] 
 
 
Figure 2: Factors that increase the risk of cancer 
Diet often acts as a double-edged sword role in cancer risk. 
There are articles on the occurrence of cancer due to the excessive 
intake of certain foods. For instance, red meat and processed food 
increase the occurrence of colorectal cancer; while over processing of 
food leads mainly breast or stomach cancer[6]. There is also research 
stating that scalding hot food or drinks can also increase the risk of 
cancer in the oral cavity[7].On the other hand, research has shown 
that fruits and vegetables like cabbage and berries can respectively 
reduce the chance of breast and colon cancer [8,9]. 
There is a paucity of reviews that have compiled dietary 
factors together. Further, details on the therapeutic use of diet as an 
adjunct to cancer therapy are also lacking. Hence the focus of this 
review is to highlight the various dietary factors that could either 
lead to an increase or a decrease in cancer risk.  
 
Figure 1: Role of Nutrition in Oncology 
 
2. Dietary that decreases the risk of cancer 
2.1 Fruits and vegetables 
All green vegetables or plants are known to contain 
chlorophyll for their light capturing properties. Chlorophyll is known 
to be converted into pheophytin, pyro pheophytin, and pheophorbide 
when processed vegetable food is ingested by humans. The 
antimutagenic and tumoricidal potencies of these compounds were 
found to be effective against the mutagen, 3-methylcholanthrene (3-
MC) [10]. Chlorophyll itself is involved in the reduction of 
carcinogenic uptake and is shown to elevate the secretion of 
mutagenic compounds like aflatoxin, which has been confirmed using 
rodent models [11,12]. 
In cruciferous vegetables, the presence of sulforaphane, an 
isothiocyanate is found to be effective in the reduction of the risk of 
prostate cancer. Sulforaphane is known to induce inhibition of the 
proliferation of prostate cancer cells and the subsequent apoptosis of 
the same [13–15]. It is seen that the mean content of sulforaphane in 
broccoli was five times more than that of cabbage. In broccoli, the 
florets were found to contain more sulforaphane than the leaves [16]. 
Brassica or Chinese cabbage consumption by the majority 
of the Eastern female population has been linked to a lower incidence 
of breast cancer, as that compared to the Western population. Animal 
studies showed that the cabbage have certain factors like 
isothiocyanates (ITC) and other glucosinolate derivatives capable of 
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inducing Phase II enzymes involved in detoxification [17], interact 
with estrogens metabolism [18–21] and reduce the estrogen level 
and finally, causes apoptosis of tumorigenic cells [22–25].  
N. Seeram et al(2006) observed a relationship between the 
antioxidant property of berries and an increased inhibition of cell 
proliferation. The berry extracts were also seen to stimulate 
apoptosis in COX-2 expressing colon cancer cell lines. Black 
raspberry and strawberry extracts were shown to have the most 
significant pro-apoptotic effects [9].  
A huge study consisting of around>5,00,000 individuals 
(men and women) around Europe was performed for a decade, to 
find out the exact relation between fruits, vegetables and cereal 
intake, with respect to cancer. A brief summary is as follows: There is 
no substantial relation between the consumption of fruits and certain 
cancers. (for eg., cancer of the pharynx, larynx, breast). However, it 
was found that the consumption of cereal fibre is proved to reduce to 
chance of colorectal cancer [26]. In another study, intake of fruits was 
beneficial for lung cancer among smokers, which may be due to the 
action of anti-oxidants present in the fruits that may act against the 
oxidative stress produced during smoking [27].   
Thus the consumption of fruits and vegetables, and finding 
the exact element that plays a vital role in the prevention of cancer is 
difficult to analyse, as it depends on many factors [28]. The 
determination of single component effect on cancer is masked by the 
cumulative effect by protectors (for eg., beta-carotene, vitamin E, 
calcium)[29,30]. This could probably be the reason for observing a 
mixed association of fruits and vegetables with cancer.  
2.2 Nuts and seeds 
Nuts are also seen to have a role in reducing cancer risk. 
Although there are some studies that point out that there is no 
relation between the consumption of nuts and cancer, there are 
speculations that the regular consumption of the same can prevent 
tumours of the colon, rectum and prostate [31]. Potential 
mechanisms through which nuts can aid is through their anti-oxidant 
property, DNA repair mechanism, and through the supply of 
monounsaturated fatty acids and fibre [32,33].   
Flax seed is known to be an excellent source of fibre, 
omega 3 fat, and lignans. The lignans are metabolized into enterodiol 
and enterolactone in the digestive tract[34,35].  The flaxseed lignan, 
as well as the mammalian metabolites, have various health benefits 
ranging from the prevention of breast cancer to colon cancers[35,36]. 
Brazil nuts are known to have a variety of nutrients 
ranging from polyunsaturated fats to phytochemicals that include 
tocopherol and squalene. Brazil nuts are known to have a great 
amount of selenium. It is found that a selenium supplementation is 
shown to reduce the incidence of prostate cancer in individuals, and 
especially more so when the individual has lower levels of baseline 
selenium levels [37]. The intake of Brazil nuts can also help prevent 
mammary cancer, as reported by Ip and Lisk (1994) [38]. 
2.3 Vitamins 
(I) Folic acid and vitamin  B12 
Folic acid and vitamin B12 are involved in DNA 
synthesis and DNA methylation. Therefore, a deficiency of these 
factors may lead to a higher mutation rate, followed by a high 
risk of either stomach or skin cancer [39–41]. In the study 
conducted by Kana Wu et al(1999), there was no significant 
relation between folate and breast risk cancer. However, a 
higher risk was found in individuals who had lower levels of 
vitamin B 12 [42]. It was concluded that since vitamin B12 is 
involved in the de novo synthesis of methyl groups, a deficiency 
would result in carcinogenesis [43]. Shumin M. Zhang et al. 
(2008) conducted a randomized trial of women to find the 
relation between vitamin B6, vitamin B12, and  folate and found 
that there was neither harmful nor beneficial towards cancer 
risks [44]. 
 
 
(II) Vitamin D 
Vitamin D is considered to have anti-cancerous effects, 
and can be considered as a potent chemoprotective agent against 
cancer [45]. The steroidal hormone 1,25-dihydroxyvitamin D3, the 
active metabolite of vitamin D, is being extensively studied in its 
possible role in cancer treatment including prostate, breast, and 
pancreatic cancer [46,47]. However, the only drawback of this 
hormone is hypercalcaemia, and hence other analogues are studied 
to replace this hormone.  
2.4 Antioxidants 
(i) β- Carotene: 
Beta-carotene is an antioxidant, part of a family of oxidants 
known as carotenoids [48].Since this compound is found in many 
vegetables and fruits, it was believed  that high doses of beta- 
carotene could lead to the prevention of cancer. However, many 
studies showed a negative result, and in two case studies, high doses 
in the form of supplements were found to increase the risk of lung 
cancer,  and a third case study showed that there was neither any 
harm nor benefit [49–51]. In a long-term study conducted by K. T 
Kelsey et al(1998), a large-scale experiment involving males was 
done to analyse the effect of β- carotene and the risk of cancer. The 
result showed that there was no statistically significant benefit/ harm 
towards malignant neoplasms when supplemented with 12 years of 
carotene [52]. However, the study suggests that certain 
micronutrients like vitamin E may be more effective in the 
prevention of cancer [53–55]. 
(ii) Lycopene: 
Consumption of the carotenoid, lycopene is shown to 
reduce the risk of prostate cancer. Tomatoes are a major source of 
lycopene, and it has also been shown that the consumption of 
tomatoes has an inverse effect on the risk of cancer [56]. In a study by 
Peter H. Gann et al(1999), many such antioxidant levels were 
examined in male participants, and it was seen that only lycopene 
had consistent serum levels in relation to prostate cancer. The link 
between lycopene and prostate cancer is still unknown, and the exact 
mechanism is still under investigation. The absorption of lycopene 
and the bioavailability in the individual remains to be a complex 
mechanism depending on the food processing, lipid intake and 
cooking method [57]. 
(III) Vitamin C: 
Vitamin C is known to reduce cancer risk, being present in 
a number of fruits and vegetables, particularly oranges, grapefruits, 
and peppers. Many studies have correlated a reduction in cancer risk 
while consuming vitamin C-rich food [58,59]. However, the intake of 
vitamin C supplements does not have a significant effect on reducing 
cancer risk [60]. 
2.7 Minerals: 
Zinc has a big role in cellular differentiation and cell 
growth. The effect of zinc can be double-edged. On one hand, a 
deficiency of zinc can lead to an increase in prostate cancer, on the 
other- the presence of zinc aids in the proliferation of tumour cells. 
Specific tissues have a higher accumulation of zinc, and this can lead 
to the incidence of cancer. For example, cancerous breast cells tend to 
accumulate more zinc than a normal breast cell. In other tissues, 
there is a significant reduction of zinc concentration in the cancerous 
cell as compared to the normal cell [61,62]. 
Carcinogens have been found to increase sodium content 
and decrease potassium content. Sodium has been shown to increase 
tumour proliferation, contrary to potassium [63]. Besides the ratio of 
calcium and magnesium must also be delicately managed, as the 
deficiency of these two minerals can lead to the production of 
mutations in the cell, favouring DNA mutations [64]. 
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3. Dietary factors that increase the risk of cancer 
3.1 Over-eating: 
Most of the studies are often based on two major concepts, 
which include either finding the extent of malignant effects that are 
brought upon through overeating, or analyzing the protective 
benefits of eating less. Obesity, often tied to increasing Type II 
diabetes as well as cardiovascular diseases risks, also plays a role in 
contributing towards cancer risk. The physiological levels of peptide 
and steroid hormones and their binding factors are mainly affected 
by poor metabolism due to obesity.  Overeating and obesity is clearly 
related to a higher cancer risk and can lead to colon and rectum 
cancers, the cancer of the liver  and cancers in the breasts of 
postmenopausal women [48]. 
There are few studies on the relation between losing 
weight and a reduction in risk of cancer, but it is believed that losing 
weight can lead to a reduction in breast cancers, and others [65]. In a 
study of around 7500 women participants were analysed for the 
effect of low-calorie intake on breast cancer risk. The conclusion is 
that severe calorie restriction confers to a lower incidence of breast 
cancer [66]. Fung T. et al(2003) had studied the effect of two major 
dietary patterns, the "prudent" and " Western" patterns on the risk of 
colon cancer. The "prudent" lifestyle was associated with a high 
intake of fruits, vegetables, and high fibre content. The "western" 
dietary pattern refers to a high intake of red meats, desserts, and 
processed foods. While no relation between prudent diets and colon 
cancer was found, a high risk of colon cancer was associated with a 
Western dietary pattern [67]. The results presented by EPIC 
(European Prospective Investigation into Cancer and Nutrition) 
showed that the consumption of red meat, processed food, high 
alcohol intake, abdominal obesity and a high BMI are risk factors 
towards colorectal cancer. Women, with high BMI, are also at risk of 
breast cancer [68]. Also, the energy consumed by those who 
frequented fast-food joints was found to be more than the low 
consumers [69]. 
3.2 Meat: 
The intake of red meat is frequently associated with the 
risk of colon cancer. A study was conducted to test the effects of meat 
and vegetable fibre on a group of male participants, who had 
answered a detailed questionnaire about their dietary habits. It was 
found that again, the red meat had a significant impact on the risk of 
colon cancer, and no association was found between animal fat and 
colon cancer [70]. Another study had analysed the level of N-
acetyltransferase (NAT) which activates several carcinogenic 
heterocyclic amines that form DNA adducts in the colon epithelium. 
The association of red meat consumption with colorectal cancer was 
stronger in men due to a rapid acetylation at the NAT enzyme, 
especially in older men (> 60 years of age) [52]. 
3.3 Processing of Food: 
  Processing of certain types of foods is known to increase 
the incidence of cancer. For example, the charring of meats increases 
the presence of carcinogens, like amino-l-methyl-6-phenylimidazo 
4,5- A pyridine, found mainly in pyrolysate products of meat and 
fishes. This carcinogen is known to produce colon and rectal cancers 
in mice models [71]. It is also seen that this carcinogen acts as an 
"initiator", as well as an organ and lobe-specific "promoter". This 
suggests that the carcinogen uses inflammatory mechanisms to 
induce cancer in the rat ventral prostate [72]. 
Processed food that uses nitrates as a preservative is 
known to be associated with an increased risk of colon and stomach 
cancer [58,73]. Finally, diets with high levels of salt and sugar uptake 
are known to increase cancer risk levels [48]. 
3.4 Adulterants: 
Consumers must be wary while buying fruits and 
vegetables. Pesticides and herbicides used to increase crop yields in 
farms have shown to have an effect on increasing cancer risks. 
Organochlorines, creosote, and sulfate are found to be carcinogenic. 
The well-known organochlorine, DDT is a tumour promoter [74].  
Argemone oil and butter yellow are common adulterants 
of edible oil and has seen to increase the occurrence of gallbladder 
carcinoma [75].There are also cases wherein injectable dyes are used 
for artificial ripening of  fruits like watermelon and mangoes. These 
dyes are reported to contain calcium carbide and formalin and are 
known to be toxic and carcinogenic. Another adulterant is "metanil- 
yellow", used to dye pulses and turmeric powder. This dye is a "coal-
tar dye" which is also found to be carcinogenic towards hepatic cells 
[76]. 
 
4. Nutrition as an adjuvant for the treatment of 
cancer 
Diet can act as an adjuvant to cancer treatment. For 
example,fermented soy products which have a high content of 
isoflavones has been reported to have anti-estrogenic activity. 
Consumption of such products has the  decreased incidence of 
mortality and recurrence of breast cancer [77]. High dose Selenium 
Therapy and the FASN therapy are used to treat cancer. 
4.1 Synergistic effect- cancer therapeutic agent vs. nutrition 
Selenium (Se) is an important mineral that is required for 
many cellular processes [78], and Se is also seen to have a preventive 
function of some forms of cancer,  mainly because it is a component 
of several selenoproteins [79,80]. Selenium acts on inducing 
apoptosis in tumour cells. The mechanism of apoptosis induction is 
variable depending on the structure, metabolism, and type of cell line. 
For eg, methyl selenol inhibits the extracellular signal-related kinase 
pathway activation in  fibrosarcoma tumour cells [81]. Glioma and 
melanoma are two types of malignant tumours that cannot be treated 
with conventional chemotherapeutic measures. Temozolomide 
(TMZ) is a DNA alkylating agent that is used in the treatment of many 
human diseases like glioma and melanoma, TMZ, being a frontline 
drug often gives disappointing results.  An experiment was conducted 
to study the effects of Se along with TMZ. The results showed a 
pronounced cytotoxicity against glioma and melanoma cells when 
TMZ was used along with Se than just TMZ alone. Also, those cells 
that show resistance towards TMZ were also cleared by TMZ-Se. This 
study demonstrates that  producing complexes with Se could 
increase the efficiency of chemotherapeutic drugs [82].A 
supplementation of selenium based food products to this type of 
therapy could lead to a significant decrease in the incidence of 
carcinomas [83]. As mentioned above, nuts are a rich source of 
selenium and can thus be used as a supplement to this therapy and 
can be used as an adjuvant therapeutic agent.  
Fatty Acid Synthase (FASN) is a multifunctional enzyme 
that is required for the endogenous synthesis of long-chain fatty acids 
from the precursor's acetyl- CoA and malonyl- CoA [84]. When this 
enzyme is blocked, human cancer cells that overexpress FASN are 
subjected to cytotoxicity[85]. FASN inhibition also shows a novel 
therapeutic agent for the treatment of multiple myelomas (MM), this 
was seen using the small molecular inhibitor Cerulenin. This 
molecule had triggered caspase- independent apoptosis in MM cell 
lines and  resulted in the cytotoxicity of these cells [86]. The 
drawback of inhibiting FASN is that the enzyme triggers anorexia and 
weight loss in patients. This can be circumscribed by the use of 
epigallocatechin-3-gallate (EGCG), found in green tea. The results 
were found to correlate the action of EGCG from green tea, and 
inhibition of FASN with anti-cancerous activity, without the 
previously mentioned drawback [87]. 
 
5. Conclusion 
From this review, it can be concluded that nutrition acts as 
a double-edged sword. On one hand, cruciferous vegetables like 
cabbage and broccoli have found to have a significant effect on 
reducing the chance of breast cancer. Intake of antioxidants like β-
carotene and lycopene also show a reduction in chronic 
inflammation, which is key to cancer development. Fruits like berries, 
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have anti-oxidant effects, and can reduce the chances of lung cancer 
in smokers. On the other hand, over processed foods can lead to 
cancer. Besides, additives like nitrates and the intentional addition of 
adulterants seem to only aggravate the occurrence of cancer.  
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